SR
Sorrento Therapeutics, Inc.
SRNE · OTC
$0.00 +0.00% (+$0.00)
1M +100.00%
Analysis
An AI report on the business, its finances, valuation, sentiment, news and risks - written in a few minutes.
Piotroski F-Score Weak
3/9Valuation
-
N/A P/E N/A
EV/EBITDA N/A
P/S N/A
Growth
100 /100
Growing Rev. growth 25.98%
EPS growth N/A
FCF growth N/A
Profitability
-
N/A Gross margin N/A
Net margin N/A
Op. margin N/A
Quality
-
N/A ROIC N/A
ROE N/A
ROA N/A
Debt
-
N/A Debt/Equity N/A
Current ratio N/A
Int. coverage N/A
Stability
50 /100
Moderate Beta 0.12x
Rev. volatility 6.83%
EPS volatility 31.57%
Bulios Scoring describes a company's quality and track record, not its future return. A high score is not a buy signal. Learn more
Ask StockBot about SRNE
Online
Sector
Healthcare
Industry
Biotechnology
CEO
Henry H. Ji
Employees
949
Headquarters
San Diego
Upcoming events
06 NOV
Earnings
Upcoming earnings report